Risk Factor Analysis Of Idiopathic Pneumonia Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation In Children

被引:0
|
作者
Sano, Hirozumi
Kobayashi, Ryoji
Iguchi, Akihiro
Suzuki, Daisuke
Kishimoto, Kenji
Yasuda, Kazue
Kobayashi, Kunihiko
机构
关键词
D O I
10.1182/blood.V122.21.5459.5459
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
5459
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Risk factor analysis of idiopathic pneumonia syndrome after allogeneic hematopoietic SCT in children
    Sano, H.
    Kobayashi, R.
    Iguchi, A.
    Suzuki, D.
    Kishimoto, K.
    Yasuda, K.
    Kobayashi, K.
    BONE MARROW TRANSPLANTATION, 2014, 49 (01) : 38 - 41
  • [2] Risk factor analysis of idiopathic pneumonia syndrome after allogeneic hematopoietic SCT in children
    H Sano
    R Kobayashi
    A Iguchi
    D Suzuki
    K Kishimoto
    K Yasuda
    K Kobayashi
    Bone Marrow Transplantation, 2014, 49 : 38 - 41
  • [3] Etanercept for treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation
    Frangoul, Haydar
    Koyama, Tatsuki
    Domm, Jennifer
    BLOOD, 2009, 113 (12) : 2868 - 2869
  • [4] Risk factors and outcomes of definite or clinical idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation
    Tamaki, Masaharu
    Nakasone, Hideki
    Nakamura, Yuhei
    Kawamura, Masakatsu
    Kawamura, Shunto
    Takeshita, Junko
    Yoshino, Nozomu
    Misaki, Yukiko
    Yoshimura, Kazuki
    Matsumi, Shimpei
    Gomyo, Ayumi
    Tanihara, Aki
    Okada, Yosuke
    Kusuda, Machiko
    Kameda, Kazuaki
    Akahoshi, Yu
    Kimura, Shun-ichi
    Kako, Shinichi
    Kanda, Yoshinobu
    LEUKEMIA & LYMPHOMA, 2022, 63 (09) : 2197 - 2205
  • [5] Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation
    Yanik, G
    Hellerstedt, B
    Custer, J
    Hutchison, R
    Kwon, D
    Ferrara, JLM
    Uberti, J
    Cooke, KR
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2002, 8 (07) : 395 - 400
  • [6] Incidence, Risk Factors and Outcomes of Idiopathic Pneumonia Syndrome After Allogeneic Hematopoietic Cell Transplantation
    Wenger, D.
    Triplette, M.
    Crothers, K. A.
    Cheng, G.
    Hill, J.
    Milano, F.
    Shahrir, S.
    Schoch, G.
    Vande Vusse, L. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [7] Incidence, Risk Factors, and Outcomes of Idiopathic Pneumonia Syndrome after Allogeneic Hematopoietic Cell Transplantation
    Wenger, David S.
    Triplette, Matthew
    Crothers, Kristina
    Cheng, Guang-Shing
    Hill, Joshua A.
    Milano, Filippo
    Shahrir, Shahida
    Schoch, Gary
    Vande Vusse, Lisa K.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (02) : 413 - 420
  • [8] Incidence, risks, and outcome of idiopathic pneumonia syndrome early after allogeneic hematopoietic stem cell transplantation
    Zhu, Kang-Er
    Hu, Jun-Yan
    Zhang, Tao
    Chen, Jie
    Zhong, Jun
    Lu, Yu-Hong
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2008, 81 (06) : 461 - 466
  • [9] Risk factor analysis of autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation in children
    Chang, Tsung-Yen
    Jaing, Tang-Her
    Wen, Yu-Chuan
    Huang, I-Anne
    Chen, Shin-Hsiang
    Tsay, Pei-Kwei
    MEDICINE, 2016, 95 (46)
  • [10] ACE Polymorphism and Idiopathic Pneumonia Syndrome After Allogeneic Stem Cell Transplantation
    Onizuka, Makoto
    Miyamono, Mitsuki
    Machida, Shinichiro
    Masako, Toyosaki
    Ogawa, Yoshiaki
    Kawada, Hiroshi
    Ando, Kiyoshi
    BLOOD, 2012, 120 (21)